Validation of an engineered Zika virus-like particle vaccine candidate in a mosquito-mouse transmission model
M. V. Mancini, R. Tandavanitj, T. H. Ant, S. M. Murdochy, D. D. Gingell, C. Setthapramote, P. Natsrita, A. Kohl, S. P. Sinkins, A. H. Patel, G. De Lorenzo
This study validates a ZIKV vaccine candidate by testing its efficacy in a mosquito-mouse transmission model, showing protection against disease and reduced viral transmission.
bioRxiv · Aug 8, 2022 · PreprintMicrobiology